Last updated on February 2018

Hepatocellular Carcinoma Registry in Asia

Brief description of study

This registry is designed as a multi-centre longitudinal cohort study of patients diagnosed with HCC between 1st January 2013 and 30th June 2018 in nine countries (ie, Korea, Taiwan, Thailand, Japan, China, Hong Kong, Australia, New Zealand and Singapore). Approximately 30% of the sample size will be identified retrospectively and 70% will be identified prospectively from the start date of the registry (October 2016), with an even distribution of consecutively diagnosed patients within the different years.

Clinical Study Identifier: NCT03233360

Find a site near you

Start Over

Flinders Medical Centre

Bedford Park, Australia
  Connect »